BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27329669)

  • 1. Effect of TGF-beta1 on MMP/TIMP and TGF-beta1 receptors in great saphenous veins and its significance on chronic venous insufficiency.
    Serralheiro P; Cairrão E; Maia CJ; João M; Almeida CMC; Verde I
    Phlebology; 2017 Jun; 32(5):334-341. PubMed ID: 27329669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of MMP/TIMP and TGF-β1 Receptors throughout the Clinical Progression of Chronic Venous Disease.
    Serralheiro P; Novais A; Cairrão E; Maia C; Costa Almeida CM; Verde I
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
    Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
    Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta1 upregulation in the aging varicose vein.
    Pascual G; Mendieta C; García-Honduvilla N; Corrales C; Bellón JM; Buján J
    J Vasc Res; 2007; 44(3):192-201. PubMed ID: 17337905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disequilibrium in MMPs and the tissue inhibitor of metalloproteinases in different segments of the varicose great saphenous vein wall.
    Hu X; Hu F; Xu Y; Tang J; Chu H; Zhong Y
    Int Angiol; 2019 Jun; 38(3):185-193. PubMed ID: 31058480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins.
    Berard X; Déglise S; Alonso F; Saucy F; Meda P; Bordenave L; Corpataux JM; Haefliger JA
    J Vasc Surg; 2013 May; 57(5):1371-82. PubMed ID: 23351647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of transforming growth factor β1 on the expression of matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and nuclear factor kappa B signalling pathway in the human amniotic cells WISH].
    Fan MS; Jiang ZY; Zou YF; Qu L; Zhou X; Sun LZ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jan; 48(1):29-33. PubMed ID: 23531248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
    Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; Durán WN; Pappas PJ
    J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intimal hyperplasia and expression of transforming growth factor-beta1 in saphenous veins and internal mammary arteries before coronary artery surgery.
    Friedl R; Li J; Schumacher B; Hanke H; Waltenberger J; Hannekum A; Stracke S
    Ann Thorac Surg; 2004 Oct; 78(4):1312-8. PubMed ID: 15464491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1.
    Lee YM; Kim SS; Kim HA; Suh YJ; Lee SK; Nahm DH; Park HS
    J Korean Med Sci; 2003 Feb; 18(1):97-102. PubMed ID: 12589095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
    Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
    Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heavy smoking before coronary surgical procedures affects the native matrix metalloproteinase-2 and matrix metalloproteinase-9 gene expression in saphenous vein conduits.
    Yongxin S; Wenjun D; Qiang W; Yunqing S; Liming Z; Chunsheng W
    Ann Thorac Surg; 2013 Jan; 95(1):55-61. PubMed ID: 23146278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of MMP-2, TIMP-2, TGF-β1, and decorin in Dupuytren's contracture.
    Ratajczak-Wielgomas K; Gosk J; Rabczyński J; Augoff K; Podhorska-Okołów M; Gamian A; Rutowski R
    Connect Tissue Res; 2012; 53(6):469-77. PubMed ID: 22512703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of transforming growth factor-beta signaling pathway in the wall of normal and varicose veins.
    Kowalewski R; Malkowski A; Sobolewski K; Gacko M
    Pathobiology; 2010; 77(1):1-6. PubMed ID: 20185961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
    Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B.
    Flisiak R; Al-Kadasi H; Jaroszewicz J; Prokopowicz D; Flisiak I
    World J Gastroenterol; 2004 Sep; 10(18):2661-5. PubMed ID: 15309715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta1, matrix-metalloproteinase-2 and its tissue inhibitor in patients with pseudoexfoliation glaucoma/syndrome.
    Djordjević-Jocić J; Zlatanović G; Veselinović D; Jovanović P; Djordjević V; Zvezdanović L; Stanković-Babić G; Vujanović M; Cekić S; Zenkel M; Schlotzer-Schrehardt U
    Vojnosanit Pregl; 2012 Mar; 69(3):231-6. PubMed ID: 22624408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The protein expression difference of transforming growth factor beta1, matrix metalloproteinases 1,7,9 and tissue inhibitors of matrix metalloproteinases-1 between chronic rhinosinusitis, nasal polyps and normal mucosa tissues].
    Lu X; Liu Z; Cui Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(14):633-5. PubMed ID: 16248458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular matrix production and regulation in micropatterned endothelial cells.
    Anderson DE; Hinds MT
    Biochem Biophys Res Commun; 2012 Oct; 427(1):159-64. PubMed ID: 22995321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.